Search

Search Constraints

You searched for: Author/Creator Le, B.

Search Results

9. An orally bioavailable ENPP1-selective inhibitor demonstrates superior immune preservation effects over STING agonists and confers antitumor efficacy in combination with other therapies in syngeneic tumor models. (October 2022)